
“Just because you can doesn’t mean you should” is a good mantra to have, but a @lowninstitute study revealed it may not always be followed in cardiology. Regions with the most PCI-performing physicians lead to a disproportionately higher share of patients receiving stents they’re unlikely to benefit from. In CW #391, we’ll dive into some reasons why, plus… 📊 A @JAMACardio study found a “U-shaped” association between left ventricular end-diastolic diameter and mortality. 💰 Braveheart Bio nabbed a $440M IPO to fund two Phase 3 trials of its cardiac myosin inhibitor. 🫀 ACCESS partnered with @JNJNews to help bring the newest cardiac technology to ASCs. cardiacwire.com/newsletter/l…








